Is there more underground betel nuts, will the pharmaceutical be affected?Tongrentang and other listed companies responded
Author:Zhongxin Jingwei Time:2022.09.21
Zhongxin Jingwei, September 21 (Wang Yuling) Recently, the market supervision and administration bureau issued a notice in many places, requiring local food operators to "do not sell betel nuts and betel nut products with tags and labels", and implement the national market supervision and management The requirements of betel nut should not be supervised by food.
Zhongxin Jingwei noticed that betel nut can be eaten but also medicinal. According to the inquiry of the State Drug Administration, betel nut pharmaceuticals include betel nut Sifang Pills, Wooden Ranzan Pills, and betel nut thirteen flavor pills. Will the management of betel nut have a stricter, will it affect the betel nut pharmaceutical?
This time required to remove food is not forbidden for sale
On September 19, according to WeChat news of the Yingshan County Market Supervision and Administration Bureau of Nanchong City, Sichuan Province, in accordance with the requirements of the "Notice on Strengthening the Supervision of Betel nut products" in the Office Betel nuts; for the sale of betel nuts and betel nut products for food business places, they will immediately contact the food business unit to remove the shelves.
Coincidentally, the Market Supervision and Administration Bureau of Zhejiang Yiwu, Chengdu, Sichuan, Jiangxi and other places in Zhejiang also demanded that local food operators have been removed from the betel nuts and betel nut products of food packaging and labels.
Does this mean that betel nut products will withdraw from the market since then? According to the WeChat public account of the Sichuan Luzhou Market Supervision and Administration Bureau, the State Administration of Market Supervision and Administration issued the "Notice on the Matters of the Supervision of betel nut products", and at present, the approval and supervision of food production licenses for betel nuts will no longer be implemented.
According to Hu Xueqing, deputy director of the Legal Work Committee of the Standing Committee of the Hunan Provincial People's Congress, in the past, in practice, my country has always regarded betel nut as food management. However, in 2012, the World Health Organization Cancer included betel nut fruits on a type of carcinogenic list; in 2020, the "Catalog of Food Production License" was not included in betel nut. This means that the management of betel nut can no longer use the laws, regulations and systems of food management.
Ji Jianbang, director of the Petrane Research Center of the Hainan Academy of Agricultural Sciences, told China New Jingwei that the requirements of the General Administration of Market Supervision and Administration are that betel nuts are no longer regarded as food, but management should be managed in accordance with betel nut products. Betel nut can still be able to produce normally. For how to manage, some areas, such as Hainan and Hunan, have introduced local standards and group standards. There is a set of regulatory methods suitable for the province.
Inadequate development of medicinal value, some have been discontinued
According to public information, betel nut is divided into medicinal and consumption.
In terms of pharmaceuticals, betel nuts are one of the "Four Big South Medicine". In the "Chinese Pharmacopoeia" 2020 edition, the betel nut Chinese medicine included in the Chinese Pharmacopoeia has betel nut and large abdominal skin (big abdomen hair). Edible betel nuts and medicinal betel nut have different use sites. Pharmaceutical betel nut refers to the dry and mature seeds from the betel nut of palmic plants. The edible betel nut is mostly the peel that uses betel nut fruits and adds auxiliary material processing.
According to the State Drug Administration, the current betel nut pharmaceuticals include betel nuts, wooden betel nut pills, and betel nut thirteen flavor pills. Pharmaceutical companies include Tongrentang, Harbin Pharmaceutical Group, Zhengda Pharmaceutical, and Friends Pharmaceuticals.
So, is the medicinal betel nut carcinogenic? Kang Zhen, a guest professor at China Pharmaceutical University, analyzes China Singapore Jingwei that betel nut is a Chinese medicinal material, which can improve the stagnation of the accumulation and dry stools. Cancer risk.
According to the Beijing University of Traditional Chinese Medicine's Xiang Jiawei team, betel nut has a long history in my country, and is generally considered to be non -toxic or small poison. At the same time, most of the Chinese medicines are used in the two aspects of the two aspects of production and compatibility. Xiang Jiawei's team believes that "analyzing reports on adverse reactions on betel nut in recent years, the probability of actual adverse reactions in the drug betel nut is very small."
From the actual sales level, Zhongxin Jingwei noticed that there is no large item for medicinal betel nuts. Taking the most betel nut pill produced by the pharmaceutical factory as an example, according to the data provided by the health industry data platform, Zhongkang CMH, the sales of the drugs in 2020 and 2021 were 8.33 million yuan and 11 million yuan, respectively.
Chen Shengting, Secretary -General of the Chinese Fruit Circulation Association, also stated in an interview with the media that from the perspective of the current status of industrial development, although there are about 200 types of betel nuts on the market, as of now, the output value of betel nut drugs is still not high, and the betel nut is betel nut There are few raw materials.
Zhongxin Jingwei called the Tongrentang Director's Secretary as an investor. The other party first made it clear that the betel nut Sifang Pill is not affected by the betel nut. Limited influence.
According to the State Drug Administration, the Sanjing Heihe Pharmaceuticals under Harbin Pharmaceutical Group have the production batch number of betel nut and four elimination tablets. However, when Zhongxin Jingwei called the director of the Harbin Pharmaceutical Group as an investor, the other staff said that the drug had been discontinued and had not produced it for a while.
Ji Jianbang's analysis of Zhongxin Jingwei stated that basic research on the functional ingredients of betel nut, material changes in betel nut processing, and mechanism of relevant main components are still very weak, and the safety assessment is insufficient. In terms of medicinal value development, Ji Jianbang said that the value development of betel nut drugs is still insufficient, but the government is very concerned about the development of the medicinal value of betel nut.
According to the "2022 Hainan Provincial Government Work Report", in deepening the structural reform of the agricultural supply side, we must accelerate the research on the deep processing of betel nut and the development of medicinal value.
Chen Shengting suggested in an interview with the media that the development of the betel nut industry can be from easy to difficult."Pay attention to the development of betel nut health products, veterinary drugs, etc. The development cycle is relatively short and less difficult. It can also be used from the existing Chinese patent medicines and internal preparations in the hospital.For clues, please contact Wang Yuling, the author of this article: [email protected]) (Zhongxin Jingwei APP) (The viewpoint in the article is for reference only, does not constitute investment suggestions, investment is risky, and you need to be cautious to enter the market.)
Copyright Copyright Copyright, without written authorization, no unit or individual may reprint, extract or use it in other ways.
Editor in charge: Li Zhongyuan
Pay attention to the official WeChat public account of JWVIEW (JWVIEW) to get more elite financial information.
- END -
Tongyi Aerospace: The subsidiary of the all -funded subsidiary is identified as a "special new" enterprise in Shanghai
On August 8, 2022, Tongyi Aerospace (871642.BJ) issued an announcement on the specialized new enterprise of Shanghai specialized new enterprises.The announcement shows that Shanghai Zitu New Mater
The central bank announced the operation of the payment system: As of the end of the first quarter, a total of 9.319 billion bank cards were opened across the country.
[Dahecai Cube News] On the evening of August 2, the People's Bank of China announced the overall situation of the operation system operation in the first quarter of 2022.In the first quarter of 2022,...